Global Measles Vaccine Sales Market Report 2021

Publisher Name :
Date: 04-May-2021
No. of pages: 129
Inquire Before Buying

The global Measles Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Measles Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

- Mumps Measles Rubella Vaccine, Live (MMR-II)

- Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)

Segment by Application

- Children

- Adults

The Measles Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Measles Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company

- GSK

- Sanofi-Pasteur

- Merck

- Novartis

- Pfizer

- Serum Institute of India

- China National Biotech Group

- Bavarian Nordic

- Emergent Biosolutions

- Medimmune

- Johnson & Johnson

- CSL Limited

Global Measles Vaccine Sales Market Report 2021

Table of Contents
1 Measles Vaccine Market Overview
1.1 Measles Vaccine Product Scope
1.2 Measles Vaccine Segment by Type
1.2.1 Global Measles Vaccine Sales by Type (2016 & 2021 & 2027)
1.2.2 Mumps Measles Rubella Vaccine, Live (MMR-II)
1.2.3 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
1.3 Measles Vaccine Segment by Application
1.3.1 Global Measles Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Children
1.3.3 Adults
1.4 Measles Vaccine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Measles Vaccine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Measles Vaccine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Measles Vaccine Price Trends (2016-2027)
2 Measles Vaccine Estimates and Forecasts by Region
2.1 Global Measles Vaccine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Measles Vaccine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Measles Vaccine Sales Market Share by Region (2016-2021)
2.2.2 Global Measles Vaccine Revenue Market Share by Region (2016-2021)
2.3 Global Measles Vaccine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Measles Vaccine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Measles Vaccine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Measles Vaccine Estimates and Projections (2016-2027)
2.4.2 Europe Measles Vaccine Estimates and Projections (2016-2027)
2.4.3 China Measles Vaccine Estimates and Projections (2016-2027)
2.4.4 Japan Measles Vaccine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Measles Vaccine Estimates and Projections (2016-2027)
2.4.6 India Measles Vaccine Estimates and Projections (2016-2027)
3 Global Measles Vaccine Competition Landscape by Players
3.1 Global Top Measles Vaccine Players by Sales (2016-2021)
3.2 Global Top Measles Vaccine Players by Revenue (2016-2021)
3.3 Global Measles Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Measles Vaccine as of 2020)
3.4 Global Measles Vaccine Average Price by Company (2016-2021)
3.5 Manufacturers Measles Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Measles Vaccine Market Size by Type
4.1 Global Measles Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global Measles Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global Measles Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Global Measles Vaccine Price by Type (2016-2021)
4.2 Global Measles Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Measles Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Measles Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Global Measles Vaccine Price Forecast by Type (2022-2027)
5 Global Measles Vaccine Market Size by Application
5.1 Global Measles Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global Measles Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global Measles Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Global Measles Vaccine Price by Application (2016-2021)
5.2 Global Measles Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Measles Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Measles Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Measles Vaccine Price Forecast by Application (2022-2027)
6 North America Measles Vaccine Market Facts & Figures
6.1 North America Measles Vaccine Sales by Company
6.1.1 North America Measles Vaccine Sales by Company (2016-2021)
6.1.2 North America Measles Vaccine Revenue by Company (2016-2021)
6.2 North America Measles Vaccine Sales Breakdown by Type
6.2.1 North America Measles Vaccine Sales Breakdown by Type (2016-2021)
6.2.2 North America Measles Vaccine Sales Breakdown by Type (2022-2027)
6.3 North America Measles Vaccine Sales Breakdown by Application
6.3.1 North America Measles Vaccine Sales Breakdown by Application (2016-2021)
6.3.2 North America Measles Vaccine Sales Breakdown by Application (2022-2027)
7 Europe Measles Vaccine Market Facts & Figures
7.1 Europe Measles Vaccine Sales by Company
7.1.1 Europe Measles Vaccine Sales by Company (2016-2021)
7.1.2 Europe Measles Vaccine Revenue by Company (2016-2021)
7.2 Europe Measles Vaccine Sales Breakdown by Type
7.2.1 Europe Measles Vaccine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Measles Vaccine Sales Breakdown by Type (2022-2027)
7.3 Europe Measles Vaccine Sales Breakdown by Application
7.3.1 Europe 129 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 129 Sales Breakdown by Application (2022-2027)
8 China Measles Vaccine Market Facts & Figures
8.1 China Measles Vaccine Sales by Company
8.1.1 China Measles Vaccine Sales by Company (2016-2021)
8.1.2 China Measles Vaccine Revenue by Company (2016-2021)
8.2 China Measles Vaccine Sales Breakdown by Type
8.2.1 China Measles Vaccine Sales Breakdown by Type (2016-2021)
8.2.2 China Measles Vaccine Sales Breakdown by Type (2022-2027)
8.3 China Measles Vaccine Sales Breakdown by Application
8.3.1 China 155 Sales Breakdown by Application (2016-2021)
8.3.2 China 155 Sales Breakdown by Application (2022-2027)
9 Japan Measles Vaccine Market Facts & Figures
9.1 Japan Measles Vaccine Sales by Company
9.1.1 Japan Measles Vaccine Sales by Company (2016-2021)
9.1.2 Japan Measles Vaccine Revenue by Company (2016-2021)
9.2 Japan Measles Vaccine Sales Breakdown by Type
9.2.1 Japan Measles Vaccine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Measles Vaccine Sales Breakdown by Type (2022-2027)
9.3 Japan Measles Vaccine Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Measles Vaccine Market Facts & Figures
10.1 Southeast Asia Measles Vaccine Sales by Company
10.1.1 Southeast Asia Measles Vaccine Sales by Company (2016-2021)
10.1.2 Southeast Asia Measles Vaccine Revenue by Company (2016-2021)
10.2 Southeast Asia Measles Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia Measles Vaccine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Measles Vaccine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Measles Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Measles Vaccine Market Facts & Figures
11.1 India Measles Vaccine Sales by Company
11.1.1 India Measles Vaccine Sales by Company (2016-2021)
11.1.2 India Measles Vaccine Revenue by Company (2016-2021)
11.2 India Measles Vaccine Sales Breakdown by Type
11.2.1 India Measles Vaccine Sales Breakdown by Type (2016-2021)
11.2.2 India Measles Vaccine Sales Breakdown by Type (2022-2027)
11.3 India Measles Vaccine Sales Breakdown by Application
11.3.1 India Measles Vaccine Sales Breakdown by Application (2016-2021)
11.3.2 India Measles Vaccine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Measles Vaccine Business
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Business Overview
12.1.3 GSK Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Measles Vaccine Products Offered
12.1.5 GSK Recent Development
12.2 Sanofi-Pasteur
12.2.1 Sanofi-Pasteur Corporation Information
12.2.2 Sanofi-Pasteur Business Overview
12.2.3 Sanofi-Pasteur Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sanofi-Pasteur Measles Vaccine Products Offered
12.2.5 Sanofi-Pasteur Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Business Overview
12.3.3 Merck Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Measles Vaccine Products Offered
12.3.5 Merck Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Business Overview
12.4.3 Novartis Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis Measles Vaccine Products Offered
12.4.5 Novartis Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Business Overview
12.5.3 Pfizer Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Pfizer Measles Vaccine Products Offered
12.5.5 Pfizer Recent Development
12.6 Serum Institute of India
12.6.1 Serum Institute of India Corporation Information
12.6.2 Serum Institute of India Business Overview
12.6.3 Serum Institute of India Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Serum Institute of India Measles Vaccine Products Offered
12.6.5 Serum Institute of India Recent Development
12.7 China National Biotech Group
12.7.1 China National Biotech Group Corporation Information
12.7.2 China National Biotech Group Business Overview
12.7.3 China National Biotech Group Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 China National Biotech Group Measles Vaccine Products Offered
12.7.5 China National Biotech Group Recent Development
12.8 Bavarian Nordic
12.8.1 Bavarian Nordic Corporation Information
12.8.2 Bavarian Nordic Business Overview
12.8.3 Bavarian Nordic Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bavarian Nordic Measles Vaccine Products Offered
12.8.5 Bavarian Nordic Recent Development
12.9 Emergent Biosolutions
12.9.1 Emergent Biosolutions Corporation Information
12.9.2 Emergent Biosolutions Business Overview
12.9.3 Emergent Biosolutions Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Emergent Biosolutions Measles Vaccine Products Offered
12.9.5 Emergent Biosolutions Recent Development
12.10 Medimmune
12.10.1 Medimmune Corporation Information
12.10.2 Medimmune Business Overview
12.10.3 Medimmune Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Medimmune Measles Vaccine Products Offered
12.10.5 Medimmune Recent Development
12.11 Johnson & Johnson
12.11.1 Johnson & Johnson Corporation Information
12.11.2 Johnson & Johnson Business Overview
12.11.3 Johnson & Johnson Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Johnson & Johnson Measles Vaccine Products Offered
12.11.5 Johnson & Johnson Recent Development
12.12 CSL Limited
12.12.1 CSL Limited Corporation Information
12.12.2 CSL Limited Business Overview
12.12.3 CSL Limited Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 CSL Limited Measles Vaccine Products Offered
12.12.5 CSL Limited Recent Development
13 Measles Vaccine Manufacturing Cost Analysis
13.1 Measles Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Measles Vaccine
13.4 Measles Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Measles Vaccine Distributors List
14.3 Measles Vaccine Customers
15 Market Dynamics
15.1 Measles Vaccine Market Trends
15.2 Measles Vaccine Drivers
15.3 Measles Vaccine Market Challenges
15.4 Measles Vaccine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Measles Vaccine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Measles Vaccine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Measles Vaccine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Measles Vaccine Sales (K MT) by Region (2016-2021)
Table 5. Global Measles Vaccine Sales Market Share by Region (2016-2021)
Table 6. Global Measles Vaccine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Measles Vaccine Revenue Share by Region (2016-2021)
Table 8. Global Measles Vaccine Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Measles Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Measles Vaccine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Measles Vaccine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Measles Vaccine Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Measles Vaccine Sales Share by Company (2016-2021)
Table 14. Global Measles Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Measles Vaccine Revenue Share by Company (2016-2021)
Table 16. Global Measles Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Measles Vaccine as of 2020)
Table 17. Global Measles Vaccine Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Measles Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Measles Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Measles Vaccine Sales (K MT) by Type (2016-2021)
Table 22. Global Measles Vaccine Sales Share by Type (2016-2021)
Table 23. Global Measles Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Measles Vaccine Price (USD/MT) by Type (2016-2021)
Table 25. Global Measles Vaccine Sales Share by Type (2022-2027)
Table 26. Global Measles Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Measles Vaccine Revenue Share by Type (2022-2027)
Table 28. Global Measles Vaccine Price (USD/MT) by Type (2022-2027)
Table 29. Global Measles Vaccine Sales (K MT) by Application (2016-2021)
Table 30. Global Measles Vaccine Sales Share by Application (2016-2021)
Table 31. Global Measles Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Measles Vaccine Price (USD/MT) by Application (2016-2021)
Table 33. Global Measles Vaccine Sales (K MT) by Application (2022-2027)
Table 34. Global Measles Vaccine Sales Share by Application (2022-2027)
Table 35. Global Measles Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Measles Vaccine Revenue Share by Application (2022-2027)
Table 37. Global Measles Vaccine Price (USD/MT) by Application (2022-2027)
Table 38. North America Measles Vaccine Sales (K MT) by Company (2016-2021)
Table 39. North America Measles Vaccine Sales Market Share by Company (2016-2021)
Table 40. North America Measles Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Measles Vaccine Revenue Market Share by Company (2016-2021)
Table 42. North America Measles Vaccine Sales by Type (2016-2021) & (K MT)
Table 43. North America Measles Vaccine Sales Market Share by Type (2016-2021)
Table 44. North America Measles Vaccine Sales by Type (2022-2027) & (K MT)
Table 45. North America Measles Vaccine Sales Market Share by Type (2022-2027)
Table 46. North America Measles Vaccine Sales by Application (2016-2021) & (K MT)
Table 47. North America Measles Vaccine Sales Market Share by Application (2016-2021)
Table 48. North America Measles Vaccine Sales by Application (2022-2027) & (K MT)
Table 49. North America Measles Vaccine Sales Market Share by Application (2022-2027)
Table 50. Europe Measles Vaccine Sales (K MT) by Company (2016-2021)
Table 51. Europe Measles Vaccine Sales Market Share by Company (2016-2021)
Table 52. Europe Measles Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Measles Vaccine Revenue Market Share by Company (2016-2021)
Table 54. Europe Measles Vaccine Sales by Type (2016-2021) & (K MT)
Table 55. Europe Measles Vaccine Sales Market Share by Type (2016-2021)
Table 56. Europe Measles Vaccine Sales by Type (2022-2027) & (K MT)
Table 57. Europe Measles Vaccine Sales Market Share by Type (2022-2027)
Table 58. Europe Measles Vaccine Sales by Application (2016-2021) & (K MT)
Table 59. Europe Measles Vaccine Sales Market Share by Application (2016-2021)
Table 60. Europe Measles Vaccine Sales by Application (2022-2027) & (K MT)
Table 61. Europe Measles Vaccine Sales Market Share by Application (2022-2027)
Table 62. China Measles Vaccine Sales (K MT) by Company (2016-2021)
Table 63. China Measles Vaccine Sales Market Share by Company (2016-2021)
Table 64. China Measles Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Measles Vaccine Revenue Market Share by Company (2016-2021)
Table 66. China Measles Vaccine Sales by Type (2016-2021) & (K MT)
Table 67. China Measles Vaccine Sales Market Share by Type (2016-2021)
Table 68. China Measles Vaccine Sales by Type (2022-2027) & (K MT)
Table 69. China Measles Vaccine Sales Market Share by Type (2022-2027)
Table 70. China Measles Vaccine Sales by Application (2016-2021) & (K MT)
Table 71. China Measles Vaccine Sales Market Share by Application (2016-2021)
Table 72. China Measles Vaccine Sales by Application (2022-2027) & (K MT)
Table 73. China Measles Vaccine Sales Market Share by Application (2022-2027)
Table 74. Japan Measles Vaccine Sales (K MT) by Company (2016-2021)
Table 75. Japan Measles Vaccine Sales Market Share by Company (2016-2021)
Table 76. Japan Measles Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Measles Vaccine Revenue Market Share by Company (2016-2021)
Table 78. Japan Measles Vaccine Sales by Type (2016-2021) & (K MT)
Table 79. Japan Measles Vaccine Sales Market Share by Type (2016-2021)
Table 80. Japan Measles Vaccine Sales by Type (2022-2027) & (K MT)
Table 81. Japan Measles Vaccine Sales Market Share by Type (2022-2027)
Table 82. Japan Measles Vaccine Sales by Application (2016-2021) & (K MT)
Table 83. Japan Measles Vaccine Sales Market Share by Application (2016-2021)
Table 84. Japan Measles Vaccine Sales by Application (2022-2027) & (K MT)
Table 85. Japan Measles Vaccine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Measles Vaccine Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Measles Vaccine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Measles Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Measles Vaccine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Measles Vaccine Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Measles Vaccine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Measles Vaccine Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Measles Vaccine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Measles Vaccine Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Measles Vaccine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Measles Vaccine Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Measles Vaccine Sales Market Share by Application (2022-2027)
Table 98. India Measles Vaccine Sales (K MT) by Company (2016-2021)
Table 99. India Measles Vaccine Sales Market Share by Company (2016-2021)
Table 100. India Measles Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Measles Vaccine Revenue Market Share by Company (2016-2021)
Table 102. India Measles Vaccine Sales by Type (2016-2021) & (K MT)
Table 103. India Measles Vaccine Sales Market Share by Type (2016-2021)
Table 104. India Measles Vaccine Sales by Type (2022-2027) & (K MT)
Table 105. India Measles Vaccine Sales Market Share by Type (2022-2027)
Table 106. India Measles Vaccine Sales by Application (2016-2021) & (K MT)
Table 107. India Measles Vaccine Sales Market Share by Application (2016-2021)
Table 108. India Measles Vaccine Sales by Application (2022-2027) & (K MT)
Table 109. India Measles Vaccine Sales Market Share by Application (2022-2027)
Table 110. GSK Corporation Information
Table 111. GSK Description and Business Overview
Table 112. GSK Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. GSK Measles Vaccine Product
Table 114. GSK Recent Development
Table 115. Sanofi-Pasteur Corporation Information
Table 116. Sanofi-Pasteur Description and Business Overview
Table 117. Sanofi-Pasteur Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Sanofi-Pasteur Measles Vaccine Product
Table 119. Sanofi-Pasteur Recent Development
Table 120. Merck Corporation Information
Table 121. Merck Description and Business Overview
Table 122. Merck Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Merck Measles Vaccine Product
Table 124. Merck Recent Development
Table 125. Novartis Corporation Information
Table 126. Novartis Description and Business Overview
Table 127. Novartis Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Novartis Measles Vaccine Product
Table 129. Novartis Recent Development
Table 130. Pfizer Corporation Information
Table 131. Pfizer Description and Business Overview
Table 132. Pfizer Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Pfizer Measles Vaccine Product
Table 134. Pfizer Recent Development
Table 135. Serum Institute of India Corporation Information
Table 136. Serum Institute of India Description and Business Overview
Table 137. Serum Institute of India Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Serum Institute of India Measles Vaccine Product
Table 139. Serum Institute of India Recent Development
Table 140. China National Biotech Group Corporation Information
Table 141. China National Biotech Group Description and Business Overview
Table 142. China National Biotech Group Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. China National Biotech Group Measles Vaccine Product
Table 144. China National Biotech Group Recent Development
Table 145. Bavarian Nordic Corporation Information
Table 146. Bavarian Nordic Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Bavarian Nordic Description and Business Overview
Table 148. Bavarian Nordic Measles Vaccine Product
Table 149. Bavarian Nordic Recent Development
Table 150. Emergent Biosolutions Corporation Information
Table 151. Emergent Biosolutions Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Emergent Biosolutions Description and Business Overview
Table 153. Emergent Biosolutions Measles Vaccine Product
Table 154. Emergent Biosolutions Recent Development
Table 155. Medimmune Corporation Information
Table 156. Medimmune Description and Business Overview
Table 157. Medimmune Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Medimmune Measles Vaccine Product
Table 159. Medimmune Recent Development
Table 160. Johnson & Johnson Corporation Information
Table 161. Johnson & Johnson Description and Business Overview
Table 162. Johnson & Johnson Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. Johnson & Johnson Measles Vaccine Product
Table 164. Johnson & Johnson Recent Development
Table 165. CSL Limited Corporation Information
Table 166. CSL Limited Description and Business Overview
Table 167. CSL Limited Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. CSL Limited Measles Vaccine Product
Table 169. CSL Limited Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Measles Vaccine Distributors List
Table 173. Measles Vaccine Customers List
Table 174. Measles Vaccine Market Trends
Table 175. Measles Vaccine Market Drivers
Table 176. Measles Vaccine Market Challenges
Table 177. Measles Vaccine Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Measles Vaccine Product Picture
Figure 2. Global Measles Vaccine Sales Market Share by Type in 2021 & 2027
Figure 3. Mumps Measles Rubella Vaccine, Live (MMR-II) Product Picture
Figure 4. Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Product Picture
Figure 5. Global Measles Vaccine Sales Market Share by Application in 2021 & 2027
Figure 6. Children Examples
Figure 7. Adults Examples
Figure 8. Global Measles Vaccine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Measles Vaccine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Measles Vaccine Sales (K MT) Growth Rate (2016-2027)
Figure 11. Global Measles Vaccine Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 12. Global Measles Vaccine Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Measles Vaccine Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Measles Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Measles Vaccine Sales (K MT) Growth Rate (2016-2027)
Figure 16. Europe Measles Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Measles Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Measles Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Measles Vaccine Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Measles Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Measles Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Measles Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Measles Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Measles Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Measles Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Measles Vaccine Players Market Share by Revenue in Measles Vaccine: 2016 & 2020
Figure 27. Measles Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Measles Vaccine Revenue Share by Type (2016-2021)
Figure 29. Global Measles Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Measles Vaccine Revenue Share by Application (2016-2021)
Figure 31. Global Measles Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Measles Vaccine Sales Market Share by Type in 2020
Figure 33. North America Measles Vaccine Sales Market Share by Application in 2020
Figure 34. Europe Measles Vaccine Sales Market Share by Type in 2020
Figure 35. Europe Measles Vaccine Sales Market Share by Application in 2020
Figure 36. China Measles Vaccine Sales Market Share by Type in 2020
Figure 37. China Measles Vaccine Sales Market Share by Application in 2020
Figure 38. Japan Measles Vaccine Sales Market Share by Type in 2020
Figure 39. Japan Measles Vaccine Sales Market Share by Application in 2020
Figure 40. Southeast Asia Measles Vaccine Sales Market Share by Type in 2020
Figure 41. Southeast Asia Measles Vaccine Sales Market Share by Application in 2020
Figure 42. India Measles Vaccine Sales Market Share by Type in 2020
Figure 43. India Measles Vaccine Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Measles Vaccine
Figure 46. Manufacturing Process Analysis of Measles Vaccine
Figure 47. Measles Vaccine Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
  • Global Recombinant Vaccines Sales Market Report 2021
    Published: 14-May-2021        Price: US 4000 Onwards        Pages: 120
    The global Recombinant Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Subunit Recombinant Vaccines - Atte......
  • Global Quit Smoking Drug Sales Market Report 2021
    Published: 14-May-2021        Price: US 4000 Onwards        Pages: 131
    The global Quit Smoking Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Quit Smoking Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Capsule - Spray Segment by......
  • Global Clenbuterol Sales Market Report 2021
    Published: 14-May-2021        Price: US 4000 Onwards        Pages: 140
    The global Clenbuterol market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Clenbuterol market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Tablets - Films - Aerosol - Other......
  • Global Drugs for Schistosomiasis Market Insights and Forecast to 2027
    Published: 14-May-2021        Price: US 4900 Onwards        Pages: 117
    Drugs for Schistosomiasis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drugs for Schistosomiasis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027. Segment by Type - Praziquantel - Oxamniquine - Other Segment by Application ......
  • 2020-2025 Global Vigabatrin Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 13-May-2021        Price: US 3360 Onwards        Pages: 107
    Vigabatrin is a GABA derivative that is used in combination with other agents as therapy of refractory complex partial seizures and as monotherapy for infantile spasms. Vigabatrin is associated with a paradoxical decrease in serum enzyme levels during therapy, explained by its direct inhibition of aminotransferase activity. Vigabatrin has not been convincingly linked to cases of clinically apparent liver injury, but was linked to a fatal case of Reye syndrome in a child with severe developmental......
  • 2020-2025 Global Cetirizine Hydrochloride Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 13-May-2021        Price: US 3360 Onwards        Pages: 122
    Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria. It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist. This report elaborates the market size, market characteristics, and market growth of the Cetirizine Hydrochloride industry, and breaks down according to the type, application, and consumption area of Cetirizine Hydrochloride. The......
  • 2020-2025 Global Attention Deficit Hyperactivity Disorder Drugs Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 13-May-2021        Price: US 3360 Onwards        Pages: 96
    This report elaborates the market size, market characteristics, and market growth of the Attention Deficit Hyperactivity Disorder Drugs industry, and breaks down according to the type, application, and consumption area of Attention Deficit Hyperactivity Disorder Drugs. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the ......
  • 2020-2025 Global Loratadine Syrup Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 13-May-2021        Price: US 3360 Onwards        Pages: 123
    This report elaborates the market size, market characteristics, and market growth of the Loratadine Syrup industry, and breaks down according to the type, application, and consumption area of Loratadine Syrup. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and indus......
  • 2020-2025 Global Histone Deacetylase (HDAC) Inhibitors Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 13-May-2021        Price: US 3360 Onwards        Pages: 112
    This report elaborates the market size, market characteristics, and market growth of the Histone Deacetylase (HDAC) Inhibitors industry, and breaks down according to the type, application, and consumption area of Histone Deacetylase (HDAC) Inhibitors. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs